About: William H. Frishman

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: William H. Frishman Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

member or fellow of the New York Academy of Medicine

Attributes	Values
rdf:type	Item
description	член Нью-Йоркської медичної академії (uk) member or fellow of the New York Academy of Medicine (en)
rdfs:label	William H. Frishman (cs) William H. Frishman (en) William H. Frishman (nl)
skos:prefLabel	William H. Frishman (cs) William H. Frishman (en) William H. Frishman (nl)
name	William H. Frishman (cs) William H. Frishman (en) William H. Frishman (nl)
given name	wds:Q100303887-CB897170-9DBB-4AA6-BF44-EA6D9716EFC8
given name	William
instance of	wds:Q100303887-D807231C-6E26-41FD-9ED7-F31AEC03C9A1
NL CR AUT ID	wds:Q100303887-C238EC2D-CB15-44E0-9940-624028C210D3
instance of	Homo sapiens
NL CR AUT ID	nlk20020118636
award received	wds:Q100303887-65DC6C7C-7EA8-45ED-92AA-01121B2ADCE0
award received	Fellow of the New York Academy of Medicine
skos:altLabel	William Frishman (en) William H. Frishman, MD (en)
employer	wds:Q100303887-B7DBCCD0-E10C-49EE-9360-952AD5377BDB
WorldCat Entities ID	wds:Q100303887-E5FC07C9-9730-4ECA-A674-F56DCE095598
sex or gender	wds:Q100303887-4495B637-AA44-425F-8006-C718A44F4401
ISNI	wds:Q100303887-7648F26E-120F-48A7-8366-BFB5757E2512
VIAF ID	wds:Q100303887-0912DCEB-7A34-4839-9D06-5B615A2460D6
GND ID	wds:Q100303887-6dee2f60-22d7-4c9f-b668-f1fb2fd592b8
Library of Congress authority ID	wds:Q100303887-3492810E-D8D5-45B6-B4BF-E7ADD6D2F710
Bibliothèque nationale de France ID	wds:Q100303887-481D1F29-B997-4702-AD00-9614FEE2C04F
IdRef ID	wds:Q100303887-A8EBC6A5-5221-4C97-A2A2-2F4CC82411ED
member of	wds:Q100303887-77BE56F5-E1EF-486D-88F7-10719C3BBBE4
academic degree	wds:Q100303887-FD0A14E0-B2AA-493D-A869-D737369CE28C
date of birth	wds:Q100303887-43328838-AD63-40A1-BCEF-6677258F1828
PLWABN ID	wds:Q100303887-B52B0CB0-3526-4AE8-93F8-0EFC736E22BA
family name	wds:Q100303887-D54E29E2-EE56-4C98-9BB1-09E14CC36570
National Library of Israel J9U ID	wds:Q100303887-1ED2A89A-82B4-4920-BE8E-BAF82B0BD21E
VIAF ID	http://viaf.org/viaf/74172183
GND ID	https://d-nb.info/gnd/172081920
Library of Congress authority ID	http://id.loc.gov/authorities/names/n80077174
Bibliothèque nationale de France ID	http://data.bnf.fr/ark:/12148/cb155926101#about
IdRef ID	http://www.idref.fr/119127431/id
employer	New York Medical College
WorldCat Entities ID	E39PCjHygPW4PKRFCKBRpbCytX
sex or gender	male
ISNI	0000000081546339
VIAF ID	74172183
GND ID	172081920
Library of Congress authority ID	n80077174
Bibliothèque nationale de France ID	155926101
IdRef ID	119127431
member of	New York Academy of Medicine
academic degree	Doctor of Medicine
date of birth	1946-01-01 00:00:00Z (xsd:dateTime)
PLWABN ID	9810586496605606
family name	Frishman
National Library of Israel J9U ID	987007459653405171
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q100303887
is author of	The placebo effect in cardiovascular disease. Cyclooxygenase inhibition in patients with coronary artery disease Anticoagulation in myocardial infarction: Modem approach to an old problem Pharmacologic inhibition of squalene synthase and other downstream enzymes of the cholesterol synthesis pathway: a new therapeutic approach to treatment of hypercholesterolemia Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations Hypertension: cardiovascular implications in a cohort of old old Ghrelin and the Cardiovascular System. Regional and systemic metabolic effects of angiotensin-converting enzyme inhibition during exercise in patients with severe heart failure Flavanol-rich cocoa: a cardioprotective nutraceutical Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography. Cardiovascular complications of eating disorders A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT) Application of transesophageal echocardiography to continuous intraoperative monitoring of left ventricular performance Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging Study. Comprehensive management of hypertensive emergencies and urgencies Myotonic dystrophies and the heart. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group. The demonstration of vegetations by echocardiography in bacterial endocarditis. An indication for early surgical intervention Compliance with National Cholesterol Education Program dietary and lifestyle guidelines among older women with self-reported hypercholesterolemia. The Women's Health Initiative Allopurinol as a cardiovascular drug Intravascular device infections: epidemiology, diagnosis, and management ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, Am Development of dementing illnesses in an 80-year-old volunteer cohort Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study Brown adipose tissue thermogenesis: β3-adrenoreceptors as a potential target for the treatment of obesity in humans Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope Neuropsychiatric effects of cardiovascular drug therapy Diagnosis and Treatment of Systolic Heart Failure in the Elderly Differences between male and female patients with regard to baseline demographics and clinical outcomes in the Asymptomatic Cardiac Ischemia Pilot (ACIP) Trial. Predictors of in-hospital mortality and acute myocardial infarction in thrombotic thrombocytopenic purpura Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease A randomized placebo-controlled comparison of amlodipine and atenolol in mild to moderate systemic hypertension A multidisciplinary approach for teaching systems-based practice to internal medicine residents One-year study of felodipine or placebo for stage 1 isolated systolic hypertension Women, myocardial infarction, and dementia in the very old. Cardiovascular drug therapy in the elderly Combination drug therapy with calcium-channel blockers in the treatment of systemic hypertension Drug utilization in the old old and how it relates to self-perceived health and all-cause mortality: results from the Bronx Aging Study. Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: a randomized, double-blind, placebo-controlled, parallel-group study. The Benazepril/Amlodipine Study Group Phytoestrogens as cardioprotective agents

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software